Insider Transactions in Q1 2024 at Guardant Health, Inc. (GH)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2024
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,509
-0.22%
|
$90,180
$20.63 P/Share
|
Mar 31
2024
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+0.54%
|
-
|
Mar 31
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+4.54%
|
-
|
Mar 31
2024
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,509
-0.24%
|
$90,180
$20.63 P/Share
|
Mar 31
2024
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+0.6%
|
-
|
Mar 18
2024
|
Kumud Kalia Chief Information Officer |
BUY
Open market or private purchase
|
Direct |
2,187
+14.67%
|
$37,179
$17.82 P/Share
|
Mar 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,998
+50.0%
|
-
|
Mar 15
2024
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-3.33%
|
$7,293
$17.74 P/Share
|
Mar 15
2024
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,233
+8.74%
|
-
|
Mar 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.9%
|
-
|
Mar 04
2024
|
Meghan V. Joyce Director |
SELL
Open market or private sale
|
Direct |
100
-2.16%
|
$1,900
$19.05 P/Share
|
Mar 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+1.41%
|
-
|
Mar 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
254
-2.35%
|
$4,572
$18.97 P/Share
|
Mar 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
710
+6.17%
|
-
|
Mar 01
2024
|
Amelia Merrill SVP, People |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-0.24%
|
$1,170
$18.97 P/Share
|
Mar 01
2024
|
Amelia Merrill SVP, People |
BUY
Exercise of conversion of derivative security
|
Direct |
158
+0.57%
|
-
|
Mar 01
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-0.5%
|
$1,944
$18.97 P/Share
|
Mar 01
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
263
+1.21%
|
-
|
Mar 01
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.37%
|
$2,340
$18.97 P/Share
|
Mar 01
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
316
+0.88%
|
-
|
Feb 29
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+4.75%
|
-
|
Feb 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.92%
|
-
|
Feb 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+1.43%
|
-
|
Jan 31
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
155
+5.02%
|
-
|
Jan 16
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,626
+15.8%
|
$53,008
$8.8 P/Share
|
Jan 15
2024
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,356
-10.43%
|
$32,544
$24.2 P/Share
|
Jan 15
2024
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,308
+20.28%
|
-
|
Jan 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.91%
|
-
|
Jan 07
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,171
-17.72%
|
$54,275
$25.78 P/Share
|
Jan 07
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,376
+30.5%
|
-
|
Jan 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+1.47%
|
-
|
Jan 01
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-1.85%
|
$10,800
$27.05 P/Share
|
Jan 01
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
974
+4.32%
|
-
|
Jan 01
2024
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
634
-4.17%
|
$17,118
$27.05 P/Share
|
Jan 01
2024
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,928
+11.25%
|
-
|
Jan 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
659
-8.75%
|
$17,793
$27.05 P/Share
|
Jan 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,607
+17.58%
|
-
|
Jan 01
2024
|
Amelia Merrill SVP, People |
SELL
Payment of exercise price or tax liability
|
Direct |
198
-0.72%
|
$5,346
$27.05 P/Share
|
Jan 01
2024
|
Amelia Merrill SVP, People |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+1.72%
|
-
|
Jan 01
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
549
-1.88%
|
$14,823
$27.05 P/Share
|
Jan 01
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,339
+4.38%
|
-
|
Jan 01
2024
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
703
-6.36%
|
$18,981
$27.05 P/Share
|
Jan 01
2024
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,714
+13.42%
|
-
|